Vimarsana
Biggest News Aggregation in the World

Tumour Specific News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tumour Specific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tumour Specific Today - Breaking & Trending Today

Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics - Vimarsana News

Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics

Published: April 25, 2022

Novel Cryptigen technology unlocks full potential of Tumour Specific Antigens CAMBRIDGE, England and MONTREAL, April 25, 2022 /PRNewswire/ -- Epitopea, a transatlantic cancer immunotherapeutics

Source: finanznachrichten.de
Related Topics:
United KingdomPrnewswire EpitopeaKostenloser WertpapierhandelLaurence RulleauPierre ThibaultClaude PerreaultJon MooreAdvent Life SciencesHarrington Discovery Institute University Health HoldingsPartner At Advent Life SciencesInstitute For ResearchScius CommunicationsHarrington Discovery InstituteCanadian Centre Of ExcellenceLife SciencesNovel CryptigenTumour SpecificCambridge Innovation CapitalNovateur VenturesHarrington DiscoveryUniversity HealthCanadian CentreOperating PartnerInnovation CapitalUniversity Health Holdings
Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics - Vimarsana News

Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics

Published: April 25, 2022

/PRNewswire/ -- Epitopea, a transatlantic cancer immunotherapeutics company and global leader in exploiting a new class of untapped tumour-specific antigens...

Source: prnewswire.com
Related Topics:
United KingdomLaurence RulleauPierre ThibaultClaude PerreaultJon MooreAdvent Life SciencesHarrington Discovery Institute University Health HoldingsPartner At Advent Life SciencesInstitute For ResearchScius CommunicationsHarrington Discovery InstituteCanadian Centre Of ExcellenceLife SciencesNovel CryptigenTumour SpecificCambridge Innovation CapitalNovateur VenturesHarrington DiscoveryUniversity HealthCanadian CentreOperating PartnerInnovation CapitalUniversity Health Holdings